Literature DB >> 8077415

Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio.

J F Plouffe1, S K Moore, R Davis, R R Facklam.   

Abstract

Isolates of Streptococcus pneumoniae in cultures of blood from 258 adults seen in 10 Franklin County, Ohio, hospitals from 1991 and 1992 were serotyped. Most strains (230 [89.2%]) belonged to serotypes that are included in the current pneumococcal vaccine. An additional 16 isolates (6.2%) were immunologically related to strains with serotypes that are included in the vaccine. Only 12 isolates (4.6%) were not covered by the vaccine. The rate of mortality from pneumococcal bacteremia in adults remains high (20%). While recent studies have documented the efficacy of the pneumococcal vaccine for preventing pneumococcal bacteremia (56 to 70%), use of the pneumococcal vaccine in susceptible patients by physicians remains low (19% in Franklin County). Additional efforts need to be expended to increase the use of the pneumococcal vaccine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077415      PMCID: PMC264051          DOI: 10.1128/jcm.32.6.1606-1607.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  Pneumococcal vaccine--past, present, and future.

Authors:  C V Broome; R F Breiman
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

3.  Pneumococcal immunization: from policy to practice.

Authors:  B Schwartz; R F Breiman
Journal:  JAMA       Date:  1990-09-05       Impact factor: 56.272

4.  Serotypes of respiratory isolates of Streptococcus pneumoniae compared with the capsular types included in the current pneumococcal vaccine.

Authors:  J H Jorgenson; A W Howell; L A Maher; R R Facklam
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

5.  Pneumococcal vaccine efficacy in selected populations in the United States.

Authors:  G Bolan; C V Broome; R R Facklam; B D Plikaytis; D W Fraser; W F Schlech
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

6.  Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States.

Authors:  C V Broome; R R Facklam
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

7.  The clinical effectiveness of pneumococcal vaccine in the elderly.

Authors:  R V Sims; W C Steinmann; J H McConville; L R King; W C Zwick; J S Schwartz
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

8.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

  8 in total
  3 in total

1.  Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination.

Authors:  J B Rubins; M Alter; J Loch; E N Janoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).

Authors:  Matthias Imöhl; Ralf René Reinert; Mark van der Linden
Journal:  Int J Microbiol       Date:  2010-06-30

3.  Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.

Authors:  Matthias Imöhl; Ralf René Reinert; Christina Ocklenburg; Mark van der Linden
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.